India · Delayed Price · Currency is INR SMS Pharmaceuticals Statistics
Total Valuation
BOM:532815 has a market cap or net worth of INR 31.57 billion. The enterprise value is 33.82 billion.
| Market Cap | 31.57B |
| Enterprise Value | 33.82B |
Important Dates
The last earnings date was Saturday, February 7, 2026.
| Earnings Date | Feb 7, 2026 |
| Ex-Dividend Date | Sep 22, 2025 |
Share Statistics
| Current Share Class | 93.65M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +10.24% |
| Shares Change (QoQ) | +1.68% |
| Owned by Insiders (%) | 64.29% |
| Owned by Institutions (%) | 3.21% |
| Float | 23.32M |
Valuation Ratios
The trailing PE ratio is 35.24.
| PE Ratio | 35.24 |
| Forward PE | n/a |
| PS Ratio | 3.52 |
| PB Ratio | 4.33 |
| P/TBV Ratio | 4.34 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 37.75 |
| EV / Sales | 3.77 |
| EV / EBITDA | 19.56 |
| EV / EBIT | 24.78 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.44 |
| Debt / EBITDA | 1.90 |
| Debt / FCF | n/a |
| Interest Coverage | 6.16 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 10.44% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 6.10M |
| Profits Per Employee | 609,461 |
| Employee Count | 1,470 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:532815 has paid 309.79 million in taxes.
| Income Tax | 309.79M |
| Effective Tax Rate | 25.69% |
Stock Price Statistics
The stock price has increased by +58.35% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +58.35% |
| 50-Day Moving Average | 319.94 |
| 200-Day Moving Average | 274.55 |
| Relative Strength Index (RSI) | 58.34 |
| Average Volume (20 Days) | 10,443 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:532815 had revenue of INR 8.97 billion and earned 895.91 million in profits. Earnings per share was 9.61.
| Revenue | 8.97B |
| Gross Profit | 2.91B |
| Operating Income | 1.34B |
| Pretax Income | 1.21B |
| Net Income | 895.91M |
| EBITDA | 1.70B |
| EBIT | 1.34B |
| Earnings Per Share (EPS) | 9.61 |
Balance Sheet
The company has 996.79 million in cash and 3.24 billion in debt, with a net cash position of -2.25 billion.
| Cash & Cash Equivalents | 996.79M |
| Total Debt | 3.24B |
| Net Cash | -2.25B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 7.29B |
| Book Value Per Share | 81.83 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 32.47%, with operating and profit margins of 14.94% and 9.99%.
| Gross Margin | 32.47% |
| Operating Margin | 14.94% |
| Pretax Margin | 13.44% |
| Profit Margin | 9.99% |
| EBITDA Margin | 18.95% |
| EBIT Margin | 14.94% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.40, which amounts to a dividend yield of 0.13%.
| Dividend Per Share | 0.40 |
| Dividend Yield | 0.13% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.24% |
| Shareholder Yield | -10.12% |
| Earnings Yield | 2.84% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 17, 2015. It was a forward split with a ratio of 10.
| Last Split Date | Dec 17, 2015 |
| Split Type | Forward |
| Split Ratio | 10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |